292 related articles for article (PubMed ID: 28281925)
1. Infectious prions and proteinopathies.
Barron RM
Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
[TBL] [Abstract][Full Text] [Related]
2. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
3. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of prion protein amyloid seeding from transmission of a spongiform encephalopathy.
Piccardo P; King D; Telling G; Manson JC; Barron RM
J Virol; 2013 Nov; 87(22):12349-56. PubMed ID: 24027305
[TBL] [Abstract][Full Text] [Related]
5. Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.
Raymond GJ; Race B; Hollister JR; Offerdahl DK; Moore RA; Kodali R; Raymond LD; Hughson AG; Rosenke R; Long D; Dorward DW; Baron GS
J Virol; 2012 Nov; 86(21):11763-78. PubMed ID: 22915801
[TBL] [Abstract][Full Text] [Related]
6.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of Abnormal Prion Protein in Blood of Transgenic Mice Experimentally Infected by Multiple Routes with the Agent of Variant Creutzfeldt-Jakob Disease.
Yakovleva O; Pilant T; Asher DM; Gregori L
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515154
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of prion protein in the brain that is not associated with transmissible disease.
Piccardo P; Manson JC; King D; Ghetti B; Barron RM
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4712-7. PubMed ID: 17360589
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of PrP-amyloid formation in mice without transmissible spongiform encephalopathy.
Jeffrey M; McGovern G; Chambers EV; King D; González L; Manson JC; Ghetti B; Piccardo P; Barron RM
Brain Pathol; 2012 Jan; 22(1):58-66. PubMed ID: 21645162
[TBL] [Abstract][Full Text] [Related]
10. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
11. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
12. Cofactors influence the biological properties of infectious recombinant prions.
Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
[TBL] [Abstract][Full Text] [Related]
13. De novo generation of infectious prions in vitro produces a new disease phenotype.
Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
[TBL] [Abstract][Full Text] [Related]
14.
Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
mSphere; 2017; 2(1):. PubMed ID: 28144628
[TBL] [Abstract][Full Text] [Related]
15. Defining and Assessing Analytical Performance Criteria for Transmissible Spongiform Encephalopathy-Detecting Amyloid Seeding Assays.
Gray JG; Graham C; Dudas S; Paxman E; Vuong B; Czub S
J Mol Diagn; 2016 May; 18(3):454-467. PubMed ID: 27068712
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal Infection of Wild-Type Mice with Synthetically Generated Mammalian Prion.
Wang X; McGovern G; Zhang Y; Wang F; Zha L; Jeffrey M; Ma J
PLoS Pathog; 2015 Jul; 11(7):e1004958. PubMed ID: 26136122
[TBL] [Abstract][Full Text] [Related]
17. Experimental approaches to TSE prevention via inhibition of prion formation.
Politopoulou G
Protein Pept Lett; 2004 Jun; 11(3):249-55. PubMed ID: 15182226
[TBL] [Abstract][Full Text] [Related]
18. Neuropathology of Animal Prion Diseases.
Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
[TBL] [Abstract][Full Text] [Related]
19. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
20. Prion agent diversity and species barrier.
Béringue V; Vilotte JL; Laude H
Vet Res; 2008; 39(4):47. PubMed ID: 18519020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
